Retinoic Acid Receptor α Knockdown Suppresses the Tumorigenicity of Esophageal Carcinoma via Wnt/β-catenin Pathway

Digestive Diseases and Sciences
Xiao-Mei MaoDong-Yan Shen

Abstract

Aberrant expression of retinoic acid receptor α (RARα) was correlated with diverse carcinomas such as acute promyelocytic leukemia and colorectal carcinoma. Nevertheless, the function and mechanism of RARα in esophageal carcinoma (EC) remain unclear. To investigate the expression of RARα in EC and its effect in the tumorigenesis of EC. In immunohistochemistry study, RARα was overexpressed in human EC tissues, and its overexpression was closely related to the pathological differentiation, lymph node metastasis, and clinical stages in EC patients. Functionally, RARα knockdown suppressed the proliferation and metastasis of EC cells through downregulating the expression of PCNA, Ki67, MMP7, and MMP9, as well as enhanced drug susceptibility of EC cells to 5-fluorouracil and cisplatin. Mechanistically, RARα knockdown inhibited the activity of Wnt/β-catenin pathway through reducing the phosphorylation level of GSK3β at Ser-9 and inducing phosphorylation level at Tyr-216, which resulted in downregulation of its downstream targets such as MMP7, MMP9, and P-gP. Our results demonstrated that RARα knockdown suppressed the tumorigenicity of EC via Wnt/β-catenin pathway. RARα might be a potential molecular target for EC clinical therapy.

References

Jun 18, 2002·Journal of Neurochemistry·Fumiko MukaiShinobu C Fujita
Aug 3, 2002·The Journal of Biological Chemistry·Kenneth A LongoOrmond A MacDougald
Nov 3, 2004·Nature Reviews. Drug Discovery·Hinrich GronemeyerVincent Laudet
Oct 31, 2006·Nature Cell Biology·Jong In YookStephen J Weiss
Jan 19, 2007·The European Journal of Neuroscience·Ayodeji A AsuniRichard Killick
Nov 4, 2009·Trends in Biochemical Sciences·Dianqing Wu, Weijun Pan
Jan 23, 2010·Nature Reviews. Cancer·Brian J ReidThomas L Vaughan
Jul 22, 2010·Current Topics in Medicinal Chemistry·J MolnárQ Wang
Jan 10, 2012·Leukemia·K GuptaD N Wald
Jul 23, 2013·Nature Communications·Henrik J JohanssonJanne Lehtiö
Nov 15, 2014·The New England Journal of Medicine·Amit X GargUNKNOWN DONOR Network
Dec 30, 2014·Molecular Aspects of Medicine·Alessandra di MasiClara Nervi
Jan 30, 2015·World Journal of Gastroenterology : WJG·Gui-Li HuangQing-Xi Chen
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Apr 2, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Mojtaba GolpichAbolhassan Ahmadiani
Jan 16, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Song ZhangSaijun Mo
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Apr 3, 2016·Digestive Diseases and Sciences·Saad GhausSauid Ishaq

❮ Previous
Next ❯

Citations

Mar 6, 2021·Frontiers in Oncology·Plabon Kumar DasAlfred K Lam
May 4, 2021·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Maike BuschNicole Dünker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.